CELESTE LATTO: Open Payments
NPI 1669613428 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$641 in 27 payments from 14 companies in 2025. Trend: 2023 $557 · 2024 $498 · 2025 $641
Food & beverage: $641
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $115 |
| PFIZER INC. | 5 | $94 |
| Novo Nordisk Inc | 4 | $81 |
| ABBVIE INC. | 3 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| Lilly USA, LLC | 3 | $58 |
| Boston Scientific Corporation | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Corcept Therapeutics | 1 | $22 |
Products named: NURTEC ODT, Kerendia, Rybelsus, MOUNJARO, General - Pain Management, Sunosi, TRELEGY ELLIPTA, SYNTHROID.
Industry payments across FL — which companies pay providers there.
